Evidence map›Paper›PMID 37260551›Full record

ArticleInternational journal of reproductive biomedicine2023

Testosterone propionate and

Aashish Kumar Netam, Vikas Pankaj Bhargava, Rambir Singh, Poonam Sharma

Open access · goldAbstract read
In one paragraph

Article in International journal of reproductive biomedicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Aashish Kumar NetamDepartment of Zoology, Indira Gandhi National Tribal University, Amarkantak, Madhya Pradesh, India.
Vikas Pankaj BhargavaDepartment of Zoology, Indira Gandhi National Tribal University, Amarkantak, Madhya Pradesh, India.
Rambir SinghDepartment of Horticulture, Aromatic and Medicinal Plants, Mizoram University, Aizawl, Mizoram, India.
Poonam SharmaDepartment of Zoology, Indira Gandhi National Tribal University, Amarkantak, Madhya Pradesh, India.ORCID https://orcid.org/0000-0003-1999-7309
Indira Gandhi National Tribal University · INMizoram University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The male reproductive system undergoes several adverse age-related changes like decreased hormone synthesis, sperm count, and testicular alteration that can impact on fertility. Objective: The study aims to investigate the effects of testosterone propionate (TP), and ayurvedic formulation Materials and Methods: 60 male Wistar rats were divided into 10 groups of 6 animals. Reproductive aging was induced by D-gal (150 mg/kg Bwt) exposure for 60 days. The rats were then treated by post and combination treatment with TP (2 mg/kg Bwt) and SB (6.75 mg/kg Bwt). Then sperm parameters, reproductive hormones, inflammatory markers, testicular antioxidant enzymes, steroidogenic enzymes, and histological manifestation of testis were evaluated. Results: Exposure of D-gal caused significant (p Conclusion: Both the treatment of TP and SB treatments recovered the reproductive impairments caused by D-gal. However, exogenous T supplementation via TP administration is associated with various side effects during long-term use. SB is an Ayurvedic formulation having a long history of usage in India. The current findings suggest that the SB may be used as a good alternative for potentiating reproductive function in aging males.

Indexed as

AgingD-galactoseHypogonadisminfertility.Swarna BhasmaTestisTestosterone propionate

Identifiers

PMID37260551
PMCPMC10227353
OpenAlexW4378953488

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.